Design and Rationale of the RE‐DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting

Antithrombotic management of patients with atrial fibrillation (AF) undergoing coronary stenting is complicated by the need for anticoagulant therapy for stroke prevention and dual antiplatelet therapy for prevention of stent thrombosis and coronary events. Triple antithrombotic therapy, typically c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Cannon, Christopher P., Gropper, Savion, Bhatt, Deepak L., Ellis, Stephen G., Kimura, Takeshi, Lip, Gregory Y.H., Steg, Ph. Gabriel, ten Berg, Jurriën M., Manassie, Jenny, Kreuzer, Jörg, Blatchford, Jon, Massaro, Joseph M., Brueckmann, Martina, Ferreiros Ripoll, Ernesto, Oldgren, Jonas, Hohnloser, Stefan H.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2016
Assuntos:
Trial Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5108471/
https://ncbi.nlm.nih.gov/pubmed/27565018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22572
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados